Pheonix-Based Cardiology Group Continues to Expand Access to Care Across ValleyPHOENIX, Dec. 26, 2025 /PRNewswire/ -- ...

Enginprime Medical Inc ('Enginprime'), an emerging leader in percutaneous ventricular assist device (pVAD) technologies and a ...

BrioHealth Solutions announces it has reached a major milestone with the 100th enrollment in the INNOVATE Trial of the BrioVAD® System, a Left Ventricular Assist Device (LVAD). The BrioVAD® System ...

Enginprime Medical Inc ("Enginprime"), an emerging leader in percutaneous ventricular assist device (pVAD) technologies and a Voyagers Capital portfolio company, today announced that its industry ...

EBR Systems, Inc., developer of the world’s only left ventricular wireless cardiac pacing device for heart failure, today announced that management will be presenting at the J.P. Morgan 2026 ...

LTS-101 is a one-time AAV gene therapy candidate intended to provide durable expression of the TPP1 enzyme in the central nervous system (CNS) of children with CLN2 disease FDA designations underscore ...

Cytokinetics announced FDA approval of MYQORZO™ (aficamten) to treat adults with symptomatic obstructive hypertrophic ...

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

The use of left-sided Impella microaxial flow pumps has expanded rapidly for the management of cardiogenic shock, left ...

Vektor Medical receives US FDA 510(k) clearance for its next-generation vMap technology to enhance connectivity: San Diego Saturday, December 13, 2025, 17:00 Hrs [IST] Vektor Medi ...

With the paid subscription, you also get additional benefits such as cloud storage, blood pressure monitoring, medication ...